Real-world evidence to improve outcomes for people with cancer

At Syapse, our goal is to realize the promise of precision medicine — helping to deliver the best care to every cancer patient by harnessing powerful real-world evidence.

Jump to:

What we do

Syapse is a real-world evidence company working in partnership with health systems, life sciences companies, and regulators to solve the challenges of precision medicine and drive better outcomes for people with cancer around the world.

  • A focus on the right clinical and molecular data to generate high-quality insights: unlocking value from complex, previously unstructured data and enabling providers to operationalize precision medicine.
  • A web-based tool for exploring shared, de-identified real-world data enables study feasibility assessments, identification of unmet need, post-market usage characterization, and more.
  • Through the Learning Health Network, health systems access and apply real-world insights and best practices; life sciences companies can leverage insights to aid in producing effective therapies and regulators can set frameworks for the use of real-world data.

Executive Leadership

Senior Leadership

Anna Berry, MD

SVP, Molecular Medicine & Customer Insights

Arun Pai

CISO & SVP, Operations

Divya Borkowski

SVP, Business Development

Jennifer Jurivich

SVP, Health Systems, Labs & Marketing

Scientific Advisory Board

Scientific and Clinical Council

George Simon, MD

Moffitt Cancer Center-AdventHealth

Guillermo Garcia-Manero, MD

MD Anderson Cancer Center

Christopher Logothetis, MD

MD Anderson Cancer Center

Marcos de Lima, MD

Ohio State University, Cleveland

Charles Drescher, MD

Swedish Cancer Institute

Benjamin Kummer, MD

Icahn School of Medicine at Mount Sinai

Brian Parkin, MD


Mark Socinski, MD


Henry Kaplan, MD

Swedish Cancer Institute

Vicente Valero, MD

MD Anderson Cancer Center


Join us in the fight against cancer.

Learn more about life at Syapse, perks, and open opportunities.